A father and son have been sentenced for orchestrating a multimillion-dollar fraud involving a small New Jersey deli. The scheme, which inflated the deli’s market value to over $100 million, highlights a sophisticated manipulation of stock prices that deceived investors and institutions alike.

As uncertainty over the global trade outlook continues, European markets are preparing for a mixed opening on Tuesday. Investors remain cautious amid lingering trade concerns.

Stocks roared back to life on Monday as the United States and China agreed to ease tariffs for 90 days, sparking optimism in the markets. The temporary reduction in trade barriers signals a potential thaw in the trade tensions between the two largest economies.

TMC the metals company Inc. has announced a $37 million investment led by Michael Hess to advance the exploration of deep-sea minerals critical to several cornerstone industries. Brian Paes-Braga of SAF Group and an existing strategic investor are also participating, marking a significant boost for the company’s ambitious projects.

In a significant move towards easing global economic tensions, the United States and China have agreed to roll back tariffs, effectively pausing their prolonged trade war. Stock markets soared as the world’s two largest economies stepped back from a clash that has unsettled the global economy.

JPMorgan has upgraded its rating on a pharmaceutical stock to overweight from neutral, following the company’s recent cost-reduction announcement. The bank also increased its price target, signaling confidence in the firm’s financial outlook.

U.S. stocks concluded an unusually quiet week with mixed results. The S&P 500 slipped 0.1% on Friday, ending the week down 0.5%, while the Dow Jones Industrial Average fell 0.3%. Investors saw minimal movement amid a tranquil trading environment.

American Healthcare REIT has reported a significant 15.1% increase in Net Operating Income (NOI) for the first quarter of 2025. This surge is attributed to gains in occupancy, signaling positive momentum for the company.

As crucial trade talks between the U.S. and China approach, markets reflect investor caution amid ongoing tariff tensions and shifting trade policies. President Trump’s recent tariff statements add uncertainty, while a new trade agreement with the U.K. offers hope for future deals.

Jefferies is urging investors to reconsider the recent sell-off of Google’s stock, calling the reaction to an Apple executive’s comments an overreaction. The financial firm’s analysis suggests that market responses may have been premature and excessive.

Global markets surged amid optimism after President Trump announced plans for a trade agreement with the United Kingdom and the rollback of semiconductor export restrictions. Investors reacted positively, propelling tech stocks and lifting US equity futures to new highs.

Despite surpassing earnings expectations for its fiscal fourth quarter, Arm Holdings faced a stock decline after issuing weaker-than-anticipated guidance. The chip designer’s outlook raised concerns among investors, overshadowing its recent performance.

Ibotta, Inc. is now under the microscope as the DJS Law Group announces an investigation into alleged securities law violations that may affect its investors. The probe could have significant implications for shareholders of the company trading under the ticker symbol IBTA.

In a recent transaction, Herbalife director Juan Miguel Mendoza has acquired $33,650 worth of company stock, as reported by Investing.com. The move highlights notable insider activity within the global nutrition company.

An exciting week lies ahead in the financial markets, but many investors remain unaware of the significant events on the horizon. As key developments approach, the markets may be primed for shifts that few are anticipating.

Tesla’s sales in Germany fell below 1,000 cars last month, signaling a significant challenge for the electric car manufacturer. This decline is the latest in a series of bad news for Tesla’s stock.

BWXT announced impressive double-digit growth across key metrics in the first quarter of 2025, reinforcing confidence in its annual outlook by reaffirming guidance. The strong performance underscores the company’s robust operations and optimistic future projections.

The CEO of Travere Therapeutics has recently sold $398,000 worth of company stock, according to a report by Investing Us. This significant insider transaction highlights executive activity within the company.

Cuprina Holdings, a biomedical company specializing in chronic wound management and cosmeceuticals, has announced the pricing of its initial public offering at $4.00 per share. The firm commitment offering includes 3,000,000 Class A Ordinary Shares, aiming to raise $12 million.

Warren Buffett has broken his silence on tariffs, warning that “Trade should not be a weapon.” The Oracle of Omaha expresses concern over global tensions and cautions against overheated markets while maintaining confidence in Berkshire Hathaway’s future under new leadership.

PLAYSTUDIOS (NASDAQ: MYPS) is poised to release its first-quarter earnings for 2025 after markets close on Monday, May 5th. Analysts predict a loss of ($0.03) per share and revenues of $64.45 million, while the company’s stock has been trading up 5.5%, opening at $1.35.